Login / Signup

The RECIST criteria compared to conventional response evaluation after peptide receptor radionuclide therapy in patients with neuroendocrine neoplasms.

Terje LøitegårdDag T BerntzenEspen Thiis-Evensen
Published in: Annals of nuclear medicine (2018)
Response evaluation after PRRT with RECIST gave more positive estimates for treatment effects compared to a method where any equivocal change in tumor load was regarded as significant. These differences had clinical implications.
Keyphrases
  • stem cells
  • replacement therapy
  • cell therapy